Katharine Yao to Biomarkers, Tumor
This is a "connection" page, showing publications Katharine Yao has written about Biomarkers, Tumor.
Connection Strength
1.033
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
Score: 0.395
-
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups. Breast Cancer Res Treat. 2015 Nov; 154(1):81-8.
Score: 0.303
-
Notch-1 and notch-4 receptors as prognostic markers in breast cancer. Int J Surg Pathol. 2011 Oct; 19(5):607-13.
Score: 0.208
-
Peritumoral expression of adipokines and fatty acids in breast cancer. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S731-8.
Score: 0.066
-
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Ann Surg Oncol. 2012 Oct; 19(10):3257-63.
Score: 0.061